Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
International Journal of Pharmaceutics|September 2, 2018
Residence time and uptake of porous and cationic maltodextrin-based nanoparticles in the nasal mucosa: Comparison with anionic and cationic nanoparticlesMinh Quan Le, Rodolphe Carpentier, Isabelle Lantier, et al.
Biomaterials|March 5, 2015
Porous nanoparticles as delivery system of complex antigens for an effective vaccine against acute and chronic Toxoplasma gondii infectionIsabelle Dimier-Poisson, Rodolphe Carpentier, Thi Thanh Loi N'Guyen, et al.
Infection and Immunity|August 23, 2003
Protective mucosal Th2 immune response against Toxoplasma gondii by murine mesenteric lymph node dendritic cellsIsabelle Dimier-Poisson, Fleur Aline, Marie-Noëlle Mévélec, et al.
International Journal of Immunopathology and Pharmacology|March 1, 2022
Immune response against toxoplasmosis-some recent updates RH: <i>Toxoplasma gondii</i> immune responseMadiha Sana, Muhammad Rashid, Imran Rashid, et al.
International Journal of Pharmaceutics: X|September 24, 2019
Protein delivery by porous cationic maltodextrin-based nanoparticles into nasal mucosal cells: Comparison with cationic or anionic nanoparticlesMinh Quan Lê, Rodolphe Carpentier, Isabelle Lantier, et al.
Medical Microbiology and Immunology|March 4, 2016
The antigen-specific response to Toxoplasma gondii profilin, a TLR11/12 ligand, depends on its intrinsic adjuvant propertiesDorsaf Hedhli, Nathalie Moiré, Haroon Akbar, et al.
Pageof 8